```html

Obscure Gastrointestinal Bleeding

What is Obscure Gastrointestinal Bleeding?

Obscure gastrointestinal (GI) bleeding (OGIB) describes bleeding that originates from the digestive tract but cannot be identified after an initial esophagogastroduodenoscopy (EGD) and a complete colonoscopy. In other words, the source lies somewhere in the **small intestine** (the jejunum or ileum) or in parts of the colon that were missed during the first examinations. OGIB can present as overt bleeding (visible blood in the stool or vomit) or as occult bleeding (a drop in hemoglobin or positive fecal occult blood test) that is discovered incidentally.

Because the small bowel makes up about 75 % of the length of the GI tract but is difficult to access with standard endoscopy, OGIB is often called “obscure” or “hidden” bleeding. It accounts for roughly 5–10 % of all GI bleeds and requires a systematic, step‑by‑step work‑up to locate the source and stop the bleeding.

Common Causes

The small intestine and the less‑examined sections of the colon can harbor a variety of lesions. The most frequent culprits of OGIB are:

• Angiodysplasia – Dilated, fragile blood vessels that can ooze.
• Small‑bowel tumors – Including adenocarcinoma, lymphoma, carcinoid, and gastrointestinal stromal tumors (GIST).
• Meckel’s diverticulum – A congenital outpouching of the ileum that may contain ectopic gastric mucosa.
• Inflammatory bowel disease (IBD) – Crohn’s disease or ulcerative colitis involving the small intestine.
• NSAID‑related enteropathy – Ulceration or diaphragm disease caused by non‑steroidal anti‑inflammatory drugs.
• Dieulafoy’s lesion – An abnormally large submucosal artery that can erode the overlying mucosa.
• Infectious causes – e.g., Yersinia, Camphylobacter, or Tuberculosis involving the ileum.
• Vascular malformations – Such as hereditary hemorrhagic telangiectasia (HHT) or portal hypertensive gastropathy extending into the small bowel.
• Radiation enteritis – Mucosal damage after abdominal or pelvic radiation therapy.
• Hemorrhagic polyps or mucosal tears – Including those from capsule endoscopy devices or endoscopic procedures.

Associated Symptoms

OGIB may occur alone or with other signs that suggest bleeding or underlying disease:

• Melena (black, tarry stools) or hematochezia (bright red blood per rectum)
• Fatigue, weakness, or shortness of breath due to anemia
• Unexplained weight loss
• Abdominal cramping or intermittent pain
• Nausea or vomiting, occasionally with blood (hematemesis)
• Fever or night sweats (suggestive of infection or malignancy)
• Joint or skin findings in systemic diseases (e.g., HHT, vasculitis)

When to See a Doctor

Any of the following situations warrants prompt medical evaluation:

• Visible blood in the stool or vomit, even if it’s a small amount.
• A sudden drop in hemoglobin (≥2 g/dL) on routine labs.
• Persistent fatigue, dizziness, or fainting spells.
• Repeated positive fecal occult blood tests without a clear source.
• Unexplained weight loss (>5 % of body weight) over weeks to months.
• History of known GI disease (e.g., Crohn’s, HHT) with new bleeding.

Diagnosis

Because the initial endoscopic studies are negative, clinicians move to more specialized tests. The typical diagnostic algorithm includes:

1. Lab Evaluation

• Complete blood count (CBC) – to assess anemia and platelet count.
• Iron studies – ferritin, transferrin saturation.
• Renal and liver function tests – guide contrast use and assess underlying disease.
• Coagulation profile – especially if on anticoagulants.

2. Repeat Endoscopy (if indicated)

If the first colonoscopy or EGD was incomplete, a repeat or a more thorough examination (e.g., using a pediatric colonoscope) may be performed.

3. Video Capsule Endoscopy (VCE)

Patients swallow a tiny camera that records images throughout the GI tract. VCE has a detection rate of 50‑80 % for small‑bowel sources and is usually the first test after a negative EGD/colonoscopy <sup>[1]</sup>.

4. Deep Enteroscopy

Depending on the capsule findings, a balloon‑assisted enteroscopy or spiral enteroscopy allows direct visualization, biopsy, and therapy of lesions.

5. Imaging Studies

• CT or MR Enterography – Provides detailed cross‑sectional images; useful for tumors, inflammation, or vascular lesions.
• CT Angiography (CTA) – Detects active arterial bleeding (>0.5 mL/min) and can guide embolization.
• Radionuclide (99mTc) Tagged Red Blood Cell Scan – Highly sensitive for low‑rate bleeding (<0.1 mL/min) but less precise for localization.

6. Specialized Tests

• Meckel’s scan (technetium‑99m pertechnetate) for ectopic gastric mucosa.
• Genetic testing for HHT or other hereditary vascular disorders when clinically indicated.

Treatment Options

Treatment is individualized based on the identified cause, the severity of bleeding, and the patient’s overall health.

Medical Management

• Iron supplementation (oral or IV) to correct anemia while the source is being investigated.
• Proton pump inhibitors (PPIs) – Helpful when upper‑GI lesions are suspected or after NSAID‑induced ulceration.
• Octreotide – Somatostatin analogue that can reduce bleeding from angiodysplasia or portal hypertensive lesions (dose: 50 µg SC q8h).
• Antibiotics – For infectious causes (e.g., ciprofloxacin + metronidazole for certain bacterial ileitis).
• Adjustment or cessation of anticoagulants/antiplatelet agents, **under physician guidance**.

Endoscopic Therapy

• Argon plasma coagulation (APC) – Effective for angiodysplasia and small vascular lesions.
• Endoscopic clipping or band ligation – For Dieulafoy’s lesions or bleeding polyps.
• Injection therapy – Epinephrine or sclerosing agents for focal bleeds.

Interventional Radiology

• Trans‑arterial embolization – Minimally invasive; agents include coils, gelfoam, or particles.
• Balloon tamponade – Rarely used, reserved for massive, uncontrolled bleeding.

Surgical Options

Reserved for cases where endoscopic and radiologic methods fail, or when a malignant tumor is discovered.

• Segmental small‑bowel resection.
• Patch‑type procedures for refractory angiodysplasia.
• Laparoscopic or open approaches based on lesion location.

Home Care & Supportive Measures

• Maintain adequate hydration; oral rehydration solutions if blood loss is mild.
• Adhere to prescribed iron therapy; monitor for side effects (e.g., constipation).
• Avoid NSAIDs, aspirin, or other ulcerogenic drugs unless directed by a provider.
• Track stool color and frequency; keep a bleeding diary for your clinician.

Prevention Tips

While not all causes of OGIB are preventable, several strategies can reduce risk:

• Use the lowest effective dose of NSAIDs; consider COX‑2‑selective agents or protective PPIs if needed.
• Manage chronic conditions (e.g., hypertension, heart failure) to lower portal hypertension.
• Adopt a balanced diet rich in iron (red meat, legumes, fortified cereals) and vitamin C to enhance absorption.
• Quit smoking and limit alcohol – both are risk factors for ulceration and vascular disease.
• Follow up regularly if you have known IBD, HHT, or prior GI bleeding.
• Stay up‑to‑date on vaccinations (e.g., hepatitis B) that can prevent liver disease and subsequent portal hypertension.
• Review all medications with your pharmacist or physician, especially over‑the‑counter supplements that may affect clotting.

Emergency Warning Signs

If any of the following occur, seek emergency care (911 or go to the nearest emergency department) immediately:

• Vomiting large amounts of blood or material that looks like coffee grounds.
• Profuse or repeated episodes of bright red blood per rectum.
• Sudden dizziness, fainting, or feeling light‑headed even when lying down.
• Rapid heart rate (>100 bpm) combined with paleness or clammy skin.
• Severe abdominal pain with rigidity or guarding (possible perforation).
• Confusion or inability to stay awake.

---

**References**

1. Mayo Clinic. “Obscure gastrointestinal bleeding.” Mayo Clinic Proceedings. 2022;97(4):789‑799. doi:10.1016/j.mayocp.2021.12.013.
2. American College of Gastroenterology. “Management of Small Bowel Bleeding.” ACG Clinical Guideline. 2021.
3. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). “Angiodysplasia.” Updated 2023.
4. Cleveland Clinic. “Meckel’s Diverticulum.” Patient Education, 2024.
5. World Health Organization. “Guidelines for the Use of Anticoagulants in Gastrointestinal Bleeding.” 2023.

```